Sunset Begins For Roche's Herceptin As Amgen/Allergan Biosimilar Launches

sunset
The sun may set for Roche's Herceptin sales as US biosimilars launch. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from Biosimilars & Generics